JP2006514057A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514057A5
JP2006514057A5 JP2004565592A JP2004565592A JP2006514057A5 JP 2006514057 A5 JP2006514057 A5 JP 2006514057A5 JP 2004565592 A JP2004565592 A JP 2004565592A JP 2004565592 A JP2004565592 A JP 2004565592A JP 2006514057 A5 JP2006514057 A5 JP 2006514057A5
Authority
JP
Japan
Prior art keywords
cytokine
composition
agonist
antagonist
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004565592A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514057A (ja
JP4727995B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/040569 external-priority patent/WO2004060291A2/en
Publication of JP2006514057A publication Critical patent/JP2006514057A/ja
Publication of JP2006514057A5 publication Critical patent/JP2006514057A5/ja
Application granted granted Critical
Publication of JP4727995B2 publication Critical patent/JP4727995B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004565592A 2002-12-31 2003-12-18 哺乳類のサイトカイン；関連試薬の使用 Expired - Fee Related JP4727995B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43751502P 2002-12-31 2002-12-31
US60/437,515 2002-12-31
PCT/US2003/040569 WO2004060291A2 (en) 2002-12-31 2003-12-18 Uses of mammalian cytokine; related reagents

Publications (3)

Publication Number Publication Date
JP2006514057A JP2006514057A (ja) 2006-04-27
JP2006514057A5 true JP2006514057A5 (enExample) 2007-02-08
JP4727995B2 JP4727995B2 (ja) 2011-07-20

Family

ID=32713193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004565592A Expired - Fee Related JP4727995B2 (ja) 2002-12-31 2003-12-18 哺乳類のサイトカイン；関連試薬の使用

Country Status (10)

Country Link
US (3) US7445779B2 (enExample)
EP (1) EP1589998B1 (enExample)
JP (1) JP4727995B2 (enExample)
AT (1) ATE506987T1 (enExample)
AU (1) AU2003301114B2 (enExample)
CA (1) CA2511838C (enExample)
DE (1) DE60336930D1 (enExample)
MX (1) MXPA05007129A (enExample)
NZ (1) NZ579795A (enExample)
WO (1) WO2004060291A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148936A0 (en) * 1999-10-20 2002-09-12 Genentech Inc Modulation of t cell differentiation for the treatment of t helper cell mediated diseases
US7393532B1 (en) * 2000-10-18 2008-07-01 Genentech, Inc. Modulation of T cell differentiation for the treatment of T helper cell mediated diseases
CA2556425A1 (en) * 2004-02-17 2005-09-01 Schering Corporation Methods of modulating il-23 activity; related reagents
EP1755641A2 (en) * 2004-02-17 2007-02-28 Schering Corporation Agonists and antagonists of p28, ebi3 and wsx/tccr for treating immune disorders
US20050287593A1 (en) 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
AU2005241020B2 (en) 2004-05-03 2008-07-10 Merck Sharp & Dohme Corp. Use of IL-17 expression to predict skin inflammation; methods of treatment
AU2005316405A1 (en) * 2004-12-16 2006-06-22 Genentech, Inc. Methods for treating autoimmune disorders
JP4839434B2 (ja) * 2005-03-14 2011-12-21 千葉県 ｐ２８分子またはその遺伝子を含む医薬製剤
DE102005049800B4 (de) * 2005-10-18 2009-09-17 Johannes-Gutenberg-Universität Mainz Verfahren zur Auffindung von Inhibitoren des Epstein-Barr-Virus-induzierten Gens 3 (EBI 3) und deren Verwendungen bei der Behandlung von metastasierenden Tumoren und allergischem Asthma
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
WO2008025033A2 (en) * 2006-08-25 2008-02-28 Zymogenetics, Inc. Use of il-27 antagonists for the manufacture of a medicament for the treatment of aplastic anemia
WO2008115597A2 (en) * 2007-03-21 2008-09-25 Cytologic, Inc. Cytokine muteins and methods for enhancing immune responses in mammals
WO2009068631A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
WO2012135598A2 (en) * 2011-03-30 2012-10-04 The Regents Of The University Of California Use of il-17d for the treatment and prevention of cancers
EP2700409A1 (en) * 2012-08-23 2014-02-26 Deutsches Rheuma-Forschungszentrum Berlin IL-27 for modulation of immune response in acute lung disease
US10426794B2 (en) 2013-04-11 2019-10-01 The Brigham And Women's Hospital, Inc. Methods and compositions of treating autoimmune diseases
WO2015157561A1 (en) * 2014-04-09 2015-10-15 La Jolla Institute For Allergy And Immunology Specific and unique t cell responses and molecular signatures for treatment and diagnosis of mycobacterium tuberculosis
CN105713876A (zh) * 2016-03-29 2016-06-29 深圳爱生再生医学科技有限公司 Cik细胞培养基及其应用
CN106754700A (zh) * 2016-12-23 2017-05-31 西安东澳生物科技有限公司 一种抗肿瘤过继免疫活性细胞cik的制备方法
EP3592778A4 (en) 2017-03-06 2021-01-13 Altor BioScience Corporation IL-15-BASED FUSIONS TO IL-12 AND IL-18
KR102265437B1 (ko) 2017-11-24 2021-06-15 의료법인 성광의료재단 Nk 배양용 조성물 및 이를 이용하여 nk 세포를 배양하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7148330B2 (en) * 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
WO2002026819A2 (en) * 2000-09-26 2002-04-04 Roger Williams Hospital Recombinant bcg vaccines for the prevention and treatment of cancer
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
IL140537A0 (en) * 2000-12-25 2002-02-10 Hadasit Med Res Service Educated nk t cells and their uses in the treatment of immune-related disorders

Similar Documents

Publication Publication Date Title
Roberts et al. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression
Steensberg et al. Strenuous exercise decreases the percentage of type 1 T cells in the circulation
Cosmi et al. Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin
George et al. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration
Takayanagi New immune connections in osteoclast formation
Wen et al. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients
JP2006507231A5 (enExample)
Claudino et al. Down‐regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin‐10 knockout mice
Mansoor et al. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients
García-Piñeres et al. Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
Oyong et al. Distinct immune responses associated with vaccination status and protection outcomes after malaria challenge
Abernathy et al. Modeling the treatment of glioblastoma multiforme and cancer stem cells with ordinary differential equations
Grover et al. Heat killed Saccharomyces cerevisiae as an adjuvant for the induction of vaccine-mediated immunity against infection with Mycobacterium tuberculosis
Moniuszko et al. Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques
Pamer Tipping the balance in favor of protective immunity during influenza virus infection
Wattegedera et al. Relative quantitative kinetics of interferon-gamma and interleukin-10 mRNA and protein production by activated ovine peripheral blood mononuclear cells
Walke Twins or two single children: The influence of the multiplicity of the first birth on the divorce risk of Swedish women
Pan et al. A single-cell atlas reveals shared and distinct immune responses and metabolism during SARS-CoV-2 and HIV-1 infections
Kim et al. Cytokine production by whole blood cells: Relationship to interleukin gene polymorphism and bone mass
MX2024002144A (es) Nueva nanoparticula lipidica termostable y metodos de uso de la misma.
Allen et al. Human placenta-derived stromal cells rescue mice from radiation-induced bone marrow failure: a Cytof-based mechanistic analysis
Sulaiman et al. Subacute cutaneous lupus erythematosus, and positive anti-MDA5 antibody in clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease: a case report and literature review
LI et al. Research on HIV/Toxoplasma gondii co‐infection and cytokine levels among intravenous drug users
Li et al. The rise of IL-2 therapy—a picture beyond Treg cells
Palma et al. Expression of the Fractalkine Receptor (CX3CR1) Is Significantly Increased in Immune Cells of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma patients with Active Disease